Neuroone Medical Technologies is trading at $1.04, down 7.14%, with no clear company-specific catalyst identified.

  • Recent company-news listings show no item explicitly dated October 5.
  • Major indices are down about 0.12%–0.20%; the mildly negative market backdrop does not clearly explain the larger decline.
  • The prior October 2 rally followed weak payroll data, not news explaining this pre-market drop.